CIC Mauricie

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis3 trials
• Rheumatoid arthritis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 23 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Avalyn Pharma Inc.3 trials

Running trials

• Recruiting

  AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

  NCT07194382· Phase 2· Avalyn Pharma Inc.· Source

  Contact: Craig S Conoscenti, MD, FCCP, ATSF

• Recruiting

  An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  NCT06951217· Phase 2· Avalyn Pharma Inc.· Source

  Contact: Emilie Millaire

• Active, not recruiting

  A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

  NCT06329401· Phase 2· Avalyn Pharma Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis2 recruiting